| 10-K | 2018-12-31 | Filed 2019-04-16 |
| 10-Q | 2018-09-30 | Filed 2018-12-03 |
| 10-Q | 2018-06-30 | Filed 2018-09-05 |
| 10-Q | 2018-03-31 | Filed 2018-08-16 |
| 10-K | 2017-12-31 | Filed 2018-06-06 |
| 10-Q | 2017-09-30 | Filed 2017-11-16 |
| 10-Q | 2017-06-30 | Filed 2017-11-09 |
| 10-Q | 2017-03-31 | Filed 2017-10-31 |
| 10-K | 2016-12-31 | Filed 2017-05-16 |
| 10-Q | 2016-10-07 | Filed 2016-10-07 |
| 10-Q | 2016-10-07 | Filed 2016-10-07 |
| 10-K | 2016-10-03 | Filed 2016-10-03 |
| 10-Q | 2016-10-03 | Filed 2016-10-03 |
| 10-Q | 2016-09-30 | Filed 2017-02-16 |
| 10-Q | 2015-06-30 | Filed 2015-08-06 |
| 10-Q | 2015-03-31 | Filed 2015-05-14 |
| 8-K | 2019-06-06 | |
| 8-K | 2019-04-16 |
| Comps ($'000 TTM) | Market Cap | Gross Margin | EV/EBITDA | Ret on Assets | Assets | Liabilities | Revenue | G Profit | Net Income | EBITDA | EV |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Luboa Group (LBAO) | 228,780 | 311.9 | 87% | 789 | 1,348 | 0 | 0 | 687 | 733 | 228,505 | |
| Invesco CurrencyShares Japanese Yen Trust (FXY) | 228,571 | 29,017.4 | -0% | 220,131 | 90 | 0 | 0 | -1,017 | -812 | -23,562,082 | |
| SpringWorks (SWTX) | 227,222 | 6.9 | -5% | 348,395 | 11,076 | 0 | 0 | -16,833 | -16,833 | -116,603 | |
| Success Entertainment Group (SEGN) | 225,300 | 53% | -408.0 | -70% | 788 | 696 | 235 | 124 | -553 | -552 | 225,293 |
| Kaleido Biosciences (KLDO) | 222,412 | -2.4 | -73% | 91,212 | 25,172 | 0 | 0 | -66,819 | -65,079 | 153,821 | |
| Citizens Financial Services (CZFS) | 219,586 | 0% | 5.7 | 1% | 1,475,005 | 1,323,327 | 5,197 | 0 | 18,962 | 34,712 | 199,500 |
| Emergent Capital (EMG) | 177,018 | 0% | -5.2 | -69% | 85,384 | 121,307 | 35,301 | 0 | -58,692 | -33,490 | 175,594 |
| Isabella Bank (ISBA) | 218,480 | 0% | 6.3 | 1% | 1,813,684 | 1,601,308 | 4,294 | 0 | 12,126 | 29,281 | 184,149 |
| Crimson Wine Group (CWGL) | 217,967 | 41% | 169.4 | -2% | 247,334 | 40,543 | 66,627 | 27,638 | -3,816 | 1,332 | 225,647 |
| Xerium Technologies (XRM) | 217,666 | 10% | 24.6 | -3% | 547,188 | 698,205 | 486,466 | 48,974 | -16,156 | 30,283 | 743,584 |
| Exicure (XCUR) | 212,785 | 0% | -7.2 | -29% | 73,806 | 8,854 | 992 | 0 | -21,077 | -20,488 | 147,392 |
| Powercomm Holdings (PCC) | 210,454 | 29% | 84.1 | 29% | 5,177 | 4,207 | 10,712 | 3,081 | 1,486 | 2,500 | 210,300 |
| Bovie Medical (BVX) | 206,243 | 65% | -11.4 | -15% | 86,943 | 10,210 | 25,892 | 16,732 | -13,330 | -12,697 | 144,111 |
| Bicycle Therapeutics (BCYC) | 200,512 | 0% | -5.3 | -17% | 116,060 | 20,735 | 2,136 | 0 | -19,699 | -19,652 | 104,558 |
| Fuse Enterprises (FSNT) | 200,164 | 86% | -191.4 | -95% | 1,099 | 2 | 1,016 | 870 | -1,046 | -1,046 | 200,124 |
| Solbright (SBRT) | 195,093 | -11% | -4.2 | -411% | 12,978 | 107,736 | 3,481 | -399 | -53,291 | -45,982 | 194,304 |
| HOOKIPA Pharma (HOOK) | 197,170 | 0% | -2.3 | -22% | 152,037 | 26,280 | 8,324 | 0 | -32,793 | -32,034 | 73,160 |
| Corvus Gold (CORVF) | 170,478 | -15.3 | -106% | 10,214 | 765 | 0 | 0 | -10,858 | -10,858 | 166,332 | |
| Union Bridge Holdings (UGHL) | 188,095 | 26% | -422.5 | -815% | 55 | 977 | 65 | 17 | -445 | -445 | 188,075 |
| IDEAYA Biosciences (IDYA) | 186,410 | -3.7 | -18% | 122,331 | 11,925 | 0 | 0 | -21,625 | -21,025 | 77,010 |
| Balance Sheet ($'000) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 |
| Cash | 50 | 45 | 212 | 389 | 715 | 499 | 975 | 629 | 154 |
| Accounts Receivable | 63 | 89 | 351 | 303 | 402 | 950 | 797 | 1,553 | 771 |
| Inventory | |||||||||
| PP&E | 2,270 | 2,311 | 2,389 | 2,682 | 2,932 | 3,141 | 3,170 | 3,395 | 5,993 |
| Assets | 886 | 864 | 1,329 | 1,683 | 2,358 | 3,038 | 3,568 | 5,944 | 5,177 |
| Accounts Payable | 132 | 153 | 180 | 313 | 302 | ||||
| Long-Term Debt | |||||||||
| Liabilities | 1,423 | 1,544 | 1,729 | 1,619 | 2,164 | 2,119 | 2,069 | 4,263 | 4,207 |
| Stockholders' Equity | -537 | -680 | -401 | 64 | 194 | 919 | 1,499 | 1,681 | 970 |
| Income Statement ($'000) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 |
| Revenue | 1,008 | 1,625 | 2,212 | 2,555 | 2,921 | 3,971 | 3,819 | ||
| Cost of Revenue | 673 | 866 | 1,264 | 1,777 | 1,825 | 2,835 | 2,971 | ||
| Gross Profit | 336 | 759 | 948 | 779 | 1,097 | 1,136 | 848 | ||
| R&D | |||||||||
| SG&A | 376 | 277 | 386 | 163 | 231 | 263 | 304 | ||
| Tax | 0 | 0 | 236 | 195 | 294 | ||||
| Net Income | -180 | 230 | 463 | -198 | 725 | 580 | 182 | ||
| Cash Flow ($'000) | 2016-12-31 | 2017-03-31 | 2017-06-30 | 2017-09-30 | 2017-12-31 | 2018-03-31 | 2018-06-30 | 2018-09-30 | 2018-12-31 |
| Cash Operating | -36 | 728 | 41 | 212 | |||||
| Cash Investing | -2 | -34 | -64 | -380 | |||||
| Cash Financing | 32 | -367 | -194 | -178 | |||||